You have 9 free searches left this month | for more free features.

City

Beijing (1)

Cincinnati (1)

Condition

B-cell Non-Hodgkin's Lymphoma (2)

CD20-positive B-cell Non-Hodgkin's Lymphoma (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (2)

phase 1 (1)

Sponsor

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (3)

Collaborator

Worldwide Clinical Trials (1)

Intervention

imm0306 (3)

lenalidomide capsule (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (3)

Study Type

Interventional (3)

imm0306

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

B-cell Non-Hodgkin's Lymphoma Trial (IMM0306, Lenalidomide capsule)

Not yet recruiting

B-cell Non-Hodgkin's Lymphoma

IMM0306
Lenalidomide capsule

(no location specified)

Mar 6, 2023

CD20-positive B-cell Non-Hodgkin's Lymphoma Trial in Beijing (IMM0306)

Recruiting

CD20-positive B-cell Non-Hodgkin's Lymphoma

IMM0306

Beijing, China

Cancer Hospital Chinese Academy of Medical Sciences

Apr 6, 2023

B-cell Non-Hodgkin's Lymphoma Trial in Cincinnati (IMM0306)

Recruiting

B-cell Non-Hodgkin's Lymphoma

IMM0306

Cincinnati, Ohio

The Christ Hospital

Apr 1, 2022